Issue details

Stop Smoking Pharmacotherapy Patient Group Directive

Living Well Smokefree are going to market to procure a Patient Group Directive (PGD) via Community Pharmacies on behalf of North Yorkshire Council. The purpose of this procurement is to enable safe and appropriate provision of stop smoking medications, via Community Pharmacy, that have returned to market within the UK. An options appraisal was completed in 2024 to explore all available routes to market before confirming that a PGD was most suitable.

Decision type: Key

Reason Key: Expenditure > £500,000;

Decision status: For Determination

Notice of proposed decision first published: 02/06/2025

Decision due: 11 Jul 2025 by Director of Public Health

Lead member: Executive Member for Health & Adult Services

Lead director: Corporate Director of Health and Adult Services

Contact: Dan Atkinson, Public Health Manager Email: Dan.Atkinson@northyorks.gov.uk / 01609 533592 Email: dan.atkinson@northyorks.gov.uk.

Documents

  • Stop Smoking Pharmacotherapy Patient Group Directive